PoliticalRepoPoliticalRepo

United Kingdom · Question · Written question

UIN 15738

Medicines and Healthcare products Regulatory Agency: Fees and Charges

answeredUnited Kingdom· UK Parliament· EN

Introduced

25 November 2024

Last action

29 November 2024 · Answer

Status

Answered

Sponsors

Subjects

Healthcare

Source updated

29 November 2024

Healthcare

Summary

To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential impact of proposed reforms to the Medicines and Healthcare products Regulatory Agency's statutory fees structures on (a) the Agency, (b) industry, (c)

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 25 November 2024

    Written question

    To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential impact of proposed reforms to the Medicines and Healthcare products Regulatory Agency's statutory fees structures on (a) the Agency, (b) industry, (c)

    Source: Commons

  2. 29 November 2024

    Answer

    The Medicines and Healthcare products Regulatory Agency (MHRA) regulates medicines, medical devices, and blood components for transfusion in the United Kingdom.Most of the MHRA’s income comes from charging fees for its services. Its fees are set to recove...

    Source: Written answer

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Sponsors

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.